Speaker illustration

Doctor Ana Isabel Rodriguez Serrano

ALTIPLANO SALUD YECLA II, Yecla (Spain)

Predictors of newer P2Y12 inhibitors prescription at discharge in a contemporary cohort of patients with acute coronary syndrome

Event: Acute Cardiovascular Care 2018

Topic: Acute Coronary Syndromes: Antiplatelet Agents

Session: General Acute Coronary Sydrome

Thumbnail

Usefulness of intrahospitalary low-density lipoprotein cholesterol levels to predict the probability of achieving LDL cholesterol target after hospital discharge for acute coronary syndrome in patient

Event: Acute Cardiovascular Care 2018

Topic: Acute Coronary Syndromes – Epidemiology, Prognosis, Outcome

Session: Biomarkers

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb